Last 12 months
Inside the activity.
7 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 6 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2017 Filed Jul 5, 2017 14:04 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 317.4258 | $33.52 | $10,640.11 |
DisclosureSEC source: 0001593968-17-000863 · primary_01.xml · derivative · entry 7 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,298.8247 Underlying: Common Stock · 317.4258 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F9 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:04 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 156.1569 | $33.52 | $5,234.38 |
DisclosureSEC source: 0001593968-17-000863 · primary_01.xml · derivative · entry 6 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,981.3989 Underlying: Common Stock · 156.1569 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F8 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:04 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 624.6271 | $33.52 | $20,937.50 |
DisclosureSEC source: 0001593968-17-000863 · primary_01.xml · derivative · entry 5 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,825.242 Underlying: Common Stock · 624.6271 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F6 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:00 UTC | GrantCommon Stock | 103.886 | $33.52 | $3,482.26 |
DisclosureSEC source: 0001593968-17-000861 · primary_01.xml · nonDerivative · entry 1 Ludwig Jeffrey G. · CIK 0001526235 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,263.821 F1 · price: Represents shares acquired by the reporting person in the ESPP pursuant to the reinvestment of dividends received during the quarter on shares held in the ESPP by the reporting person at the time such dividend was paid based upon the closing price of the underlying shares on the last day of the quarter. Read SEC document |
|
| June 30, 2017 Filed Jul 5, 2017 13:56 UTC |
Mefford Jeffrey S.EVP-Banking
|
GrantCommon Stock | 20.12 | $33.52 | $674.42 |
DisclosureSEC source: 0001593968-17-000857 · primary_01.xml · nonDerivative · entry 1 Mefford Jeffrey S. · CIK 0001526238 · EVP-Banking 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,438.033 F1 · price: Represents shares acquired by the reporting person in the ESPP pursuant to the reinvestment of dividends received during the quarter on shares held in the ESPP by the reporting person at the time such dividend was paid based upon the closing price of the underlying shares on the last day of the quarter. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:54 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 291.0307 | $33.52 | $9,755.35 |
DisclosureSEC source: 0001593968-17-000856 · primary_01.xml · derivative · entry 8 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,897.3592 Underlying: Common Stock · 291.0307 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F9 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:54 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 165.9457 | $33.52 | $5,562.50 |
DisclosureSEC source: 0001593968-17-000856 · primary_01.xml · derivative · entry 7 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,606.3285 Underlying: Common Stock · 165.9457 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F8 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:54 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 663.7828 | $33.52 | $22,250.00 |
DisclosureSEC source: 0001593968-17-000856 · primary_01.xml · derivative · entry 6 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,440.3828 Underlying: Common Stock · 663.7828 shares Expires not disclosed F5 · derivative.exercise_price: No exercise price for this type of award F6 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F7 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F7 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:49 UTC |
Brunoehler Jeffrey A.SVP Credit - CCO
|
GrantCommon Stock | 53.601 | $33.52 | $1,796.71 |
DisclosureSEC source: 0001593968-17-000853 · primary_01.xml · nonDerivative · entry 2 Brunoehler Jeffrey A. · CIK 0001526237 · SVP Credit - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,765.618 F2 · price: Represents shares acquired by the reporting person in the ESPP pursuant to the reinvestment of dividends received during the quarter on shares held in the ESPP by the reporting person at the time such dividend was paid based upon the closing price of the underlying shares on the last day of the quarter. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:49 UTC |
Brunoehler Jeffrey A.SVP Credit - CCO
|
GrantCommon Stock | 237.035 | $30.95 | $7,336.23 |
DisclosureSEC source: 0001593968-17-000853 · primary_01.xml · nonDerivative · entry 1 Brunoehler Jeffrey A. · CIK 0001526237 · SVP Credit - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,712.017 F1 · price: Represents shares acquired by the reporting person through contributions to the Employee Stock Purchase Plan of the Issuer (ESPP) for the calendar quarter. Pursuant to the ESPP, the price used for each quarterly purchase is the lower of 90% of the fair market of the Issuers shares on the first day of the calendar quarter or the closing price of the shares on the last day of the quarter. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:48 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 9.0944 | $33.52 | $304.84 |
DisclosureSEC source: 0001593968-17-000852 · primary_01.xml · derivative · entry 3 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,391.0223 Underlying: Common Stock · 9.0944 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:48 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 171.5394 | $33.52 | $5,750.00 |
DisclosureSEC source: 0001593968-17-000852 · primary_01.xml · derivative · entry 2 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381.9279 Underlying: Common Stock · 171.5394 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:48 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 686.1575 | $33.52 | $23,000.00 |
DisclosureSEC source: 0001593968-17-000852 · primary_01.xml · derivative · entry 1 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,210.3885 Underlying: Common Stock · 686.1575 shares Expires not disclosed F1 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 23, 2017 Filed Jul 5, 2017 10:03 UTC |
Shaw Thomas DDirector
|
GrantCommon Share Equivalent · Derivative | 127.1056 | $33.52 | $4,260.58 |
DisclosureSEC source: 0001593968-17-000862 · primary_01.xml · derivative · entry 4 Shaw Thomas D · CIK 0001672607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,430.0094 Underlying: Common Stock · 127.1056 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 14:49 UTC |
Tucker Douglas J.SVP Corporate Counsel
|
SaleCommon Stock | 1,954 | $34.80 | $67,989.43 |
DisclosureSEC source: 0001593968-17-000791 · primary_01.xml · nonDerivative · entry 1 Tucker Douglas J. · CIK 0001526236 · SVP Corporate Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 - 34.89 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 1 to this form. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:13 UTC |
Mefford Jeffrey S.EVP-Banking
|
SaleCommon Stock | 25,000 | $34.57 | $864,300.00 |
DisclosureSEC source: 0001593968-17-000760 · primary_01.xml · nonDerivative · entry 1 Mefford Jeffrey S. · CIK 0001526238 · EVP-Banking 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,417.913 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 - 34.80 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 1 to this form. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:12 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.41 | $34,410.00 |
DisclosureSEC source: 0001593968-17-000759 · primary_01.xml · nonDerivative · entry 2 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JNJ, LLC Disclosed balance after: 85,903 F3 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:12 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.50 | $34,499.80 |
DisclosureSEC source: 0001593968-17-000759 · primary_01.xml · nonDerivative · entry 1 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,026 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.42 - 34.6001 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 1 to this form. F2 · balance_after: Includes holdings through a self-directed IRA or revocable grantor trust Read SEC document |
| May 26, 2017 Filed Jul 5, 2017 13:54 UTC |
Schultz Robert F.Director
|
OtherCommon Stock | 208 | $34.37 | $7,148.96 |
DisclosureSEC source: 0001593968-17-000856 · primary_01.xml · nonDerivative · entry 2 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Summit Investors, LLP Disclosed balance after: 36,053 F3 · shares: 208 shares have been added to reflect automatic dividend reinvestments since the Reporting Persons last Form 4, pursuant to Rule 16a-11 F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose Read SEC document |
| May 26, 2017 Filed Jul 5, 2017 13:54 UTC |
Schultz Robert F.Director
|
OtherCommon Stock | 12 | $34.39 | $412.73 |
DisclosureSEC source: 0001593968-17-000856 · primary_01.xml · nonDerivative · entry 1 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 2,067 F1 · shares: 12 shares have been added to reflect automatic dividend reinvestments since the Reporting Persons last Form 4, pursuant to Rule 16a-11 F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose Read SEC document |
| May 01, 2017 Filed May 2, 2017 15:40 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.30 | $34,296.80 |
DisclosureSEC source: 0001593968-17-000630 · primary_01.xml · nonDerivative · entry 2 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JNJ, LLC Disclosed balance after: 86,903 F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose Read SEC document |
| May 01, 2017 Filed May 2, 2017 15:40 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.30 | $34,296.80 |
DisclosureSEC source: 0001593968-17-000630 · primary_01.xml · nonDerivative · entry 1 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,026 F1 · balance_after: Includes holdings through a self-directed IRA or revocable grantor trust Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 15:11 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.01 | $34,013.10 |
DisclosureSEC source: 0001593968-17-000561 · primary_01.xml · nonDerivative · entry 2 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JNJ, LLC Disclosed balance after: 87,903 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0001 - $34.13 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 1 to this form. F3 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 15:11 UTC |
Schultz John MDirector
|
SaleCommon Stock | 1,000 | $34.00 | $34,000.10 |
DisclosureSEC source: 0001593968-17-000561 · primary_01.xml · nonDerivative · entry 1 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,026 F1 · balance_after: Includes holdings through a self-directed IRA or revocable grantor trust Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:04 UTC |
HOLSCHBACH LEON JDirector · CEO
|
GrantCommon Share Equivalent · Derivative | 23.1919 | $34.39 | $797.57 |
DisclosureSEC source: 0001593968-17-000556 · primary_01.xml · derivative · entry 2 HOLSCHBACH LEON J · CIK 0001169100 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,011.0911 Underlying: Common Stock · 23.1919 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:08 UTC |
Thompson Kevin LChief Financial Officer
|
GrantCommon Stock | 108.437 | $32.56 | $3,530.71 |
DisclosureSEC source: 0001593968-17-000560 · primary_01.xml · nonDerivative · entry 1 Thompson Kevin L · CIK 0001689815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,458.437 F1 · price: Represents shares acquired by the reporting person through contributions to the Employee Stock Purchase Plan of the Issuer (ESPP) for the calendar quarter. Pursuant to the ESPP, the price used for each quarterly purchase is the lower of 90% of the fair market of the Issuers shares on the first day of the calendar quarter or the closing price of the shares on the last day of the quarter. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:00 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 11.1309 | $34.39 | $382.79 |
DisclosureSEC source: 0001593968-17-000552 · primary_01.xml · derivative · entry 3 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,052.2895 Underlying: Common Stock · 11.1309 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:00 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 25.4434 | $34.39 | $875.00 |
DisclosureSEC source: 0001593968-17-000552 · primary_01.xml · derivative · entry 2 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,041.1586 Underlying: Common Stock · 25.4434 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:00 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 101.7738 | $34.39 | $3,500.00 |
DisclosureSEC source: 0001593968-17-000552 · primary_01.xml · derivative · entry 1 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015.7152 Underlying: Common Stock · 101.7738 shares Expires not disclosed F1 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:03 UTC |
Shaw Thomas DDirector
|
GrantCommon Share Equivalent · Derivative | 120.2578 | $34.39 | $4,135.67 |
DisclosureSEC source: 0001593968-17-000555 · primary_01.xml · derivative · entry 6 Shaw Thomas D · CIK 0001672607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,302.9038 Underlying: Common Stock · 120.2575 shares Expires not disclosed F5 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:03 UTC |
Shaw Thomas DDirector
|
GrantCommon Share Equivalent · Derivative | 100.8651 | $34.39 | $3,468.75 |
DisclosureSEC source: 0001593968-17-000555 · primary_01.xml · derivative · entry 5 Shaw Thomas D · CIK 0001672607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,182.646 Underlying: Common Stock · 100.8651 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:03 UTC |
Shaw Thomas DDirector
|
GrantCommon Share Equivalent · Derivative | 403.4603 | $34.39 | $13,875.00 |
DisclosureSEC source: 0001593968-17-000555 · primary_01.xml · derivative · entry 4 Shaw Thomas D · CIK 0001672607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,081.7809 Underlying: Common Stock · 403.4603 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:06 UTC |
McDaniel Jerry L.Director
|
GrantCommon Share Equivalent · Derivative | 93.2977 | $34.39 | $3,208.51 |
DisclosureSEC source: 0001593968-17-000558 · primary_01.xml · derivative · entry 9 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,640.157 Underlying: Common Stock · 93.2977 shares Expires not disclosed F5 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:06 UTC |
McDaniel Jerry L.Director
|
GrantCommon Share Equivalent · Derivative | 100.8651 | $34.39 | $3,468.75 |
DisclosureSEC source: 0001593968-17-000558 · primary_01.xml · derivative · entry 8 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,546.8593 Underlying: Common Stock · 100.8651 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:06 UTC |
McDaniel Jerry L.Director
|
GrantCommon Share Equivalent · Derivative | 403.4603 | $34.39 | $13,875.00 |
DisclosureSEC source: 0001593968-17-000558 · primary_01.xml · derivative · entry 7 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,445.9942 Underlying: Common Stock · 403.4603 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F3 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F3 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:02 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 101.8981 | $34.39 | $3,504.28 |
DisclosureSEC source: 0001593968-17-000554 · primary_01.xml · derivative · entry 6 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,877.7513 Underlying: Common Stock · 101.8981 shares Expires not disclosed F6 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F4 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F4 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:02 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 50.8869 | $34.39 | $1,750.00 |
DisclosureSEC source: 0001593968-17-000554 · primary_01.xml · derivative · entry 5 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,775.8532 Underlying: Common Stock · 50.8869 shares Expires not disclosed F5 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F4 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F4 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:02 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 203.5475 | $34.39 | $7,000.00 |
DisclosureSEC source: 0001593968-17-000554 · primary_01.xml · derivative · entry 4 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,724.9663 Underlying: Common Stock · 203.5475 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F4 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F4 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:01 UTC |
Miller Dwight ADirector
|
GrantCommon Share Equivalents · Derivative | 66.3278 | $34.39 | $2,281.01 |
DisclosureSEC source: 0001593968-17-000553 · primary_01.xml · derivative · entry 4 Miller Dwight A · CIK 0001671611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,725.8049 Underlying: Common Stock · 66.3278 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:01 UTC |
Miller Dwight ADirector
|
GrantCommon Share Equivalents · Derivative | 50.8869 | $34.39 | $1,750.00 |
DisclosureSEC source: 0001593968-17-000553 · primary_01.xml · derivative · entry 3 Miller Dwight A · CIK 0001671611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,659.4771 Underlying: Common Stock · 50.8869 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 11:01 UTC |
Miller Dwight ADirector
|
GrantCommon Share Equivalents · Derivative | 203.5475 | $34.39 | $7,000.00 |
DisclosureSEC source: 0001593968-17-000553 · primary_01.xml · derivative · entry 2 Miller Dwight A · CIK 0001671611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,608.5902 Underlying: Common Stock · 203.5475 shares Expires not disclosed F1 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:56 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 8.0775 | $34.39 | $277.79 |
DisclosureSEC source: 0001593968-17-000550 · primary_01.xml · derivative · entry 3 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,524.231 Underlying: Common Stock · 8.0775 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:56 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 25.4434 | $34.39 | $875.00 |
DisclosureSEC source: 0001593968-17-000550 · primary_01.xml · derivative · entry 2 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,516.1535 Underlying: Common Stock · 25.4434 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:56 UTC |
Golden Deborah ADirector
|
GrantCommon Share Equivalents · Derivative | 101.7738 | $34.39 | $3,500.00 |
DisclosureSEC source: 0001593968-17-000550 · primary_01.xml · derivative · entry 1 Golden Deborah A · CIK 0001349480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490.7101 Underlying: Common Stock · 101.7738 shares Expires not disclosed F1 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F2 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F2 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:11 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 304.5592 | $34.39 | $10,473.79 |
DisclosureSEC source: 0001593968-17-000561 · primary_01.xml · derivative · entry 7 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,200.6149 Underlying: Common Stock · 304.5592 shares Expires not disclosed F7 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F5 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F5 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:11 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 105.4085 | $34.39 | $3,625.00 |
DisclosureSEC source: 0001593968-17-000561 · primary_01.xml · derivative · entry 6 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,896.0557 Underlying: Common Stock · 105.4085 shares Expires not disclosed F6 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F5 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F5 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:11 UTC |
Schultz John MDirector
|
GrantCommon Share Equivalent · Derivative | 421.6342 | $34.39 | $14,500.00 |
DisclosureSEC source: 0001593968-17-000561 · primary_01.xml · derivative · entry 5 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,790.6472 Underlying: Common Stock · 421.6342 shares Expires not disclosed F4 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F5 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F5 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:07 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 279.112 | $34.39 | $9,598.66 |
DisclosureSEC source: 0001593968-17-000559 · primary_01.xml · derivative · entry 8 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,776.6 Underlying: Common Stock · 279.112 shares Expires not disclosed F4 · derivative.exercise_price: No exercise price for this type of award F8 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director. F6 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F6 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:07 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 100.8651 | $34.39 | $3,468.75 |
DisclosureSEC source: 0001593968-17-000559 · primary_01.xml · derivative · entry 7 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,497.488 Underlying: Common Stock · 100.8651 shares Expires not disclosed F4 · derivative.exercise_price: No exercise price for this type of award F7 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates. F6 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F6 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:07 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 403.4603 | $34.39 | $13,875.00 |
DisclosureSEC source: 0001593968-17-000559 · primary_01.xml · derivative · entry 6 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,396.6229 Underlying: Common Stock · 403.4603 shares Expires not disclosed F4 · derivative.exercise_price: No exercise price for this type of award F5 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F6 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F6 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.